Clinical trial
Effect of DAW1033B2 on Obstructive Sleep Apnea
NCT03426631 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of DAW1033B2 on Obstructive Sleep Apnea
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 15, 2017
- Completion date
- January 20, 2020
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea (osa)